首页 › 基金 › BERNZOTT CAPITAL ADVISORS › ENOV
BERNZOTT CAPITAL ADVISORS 对 ENOV 的持仓历史
ENOVIS CORPORATION · 医疗保健
BERNZOTT CAPITAL ADVISORS 在 Q2 2025 的 13F 申报中披露持有 ENOV(ENOVIS CORPORATION)230,128 股,市值约 US$7.2M,约占其申报组合的 3.68%,在其申报持仓中市值排名第 8 位。 BERNZOTT CAPITAL ADVISORS 最近 8 个申报季度中有 8 个季度披露了 ENOV 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
BERNZOTT CAPITAL ADVISORS 对 ENOV 的持仓演变
BERNZOTT CAPITAL ADVISORS 于 Q3 2023 首次披露 ENOV 持仓:72,905 股(约 US$3.8M)。 该持仓在 Q2 2025 达到峰值 230,128 股,市值约 US$7.2M。 在 8 次申报中,BERNZOTT CAPITAL ADVISORS 4 次增持、2 次减持、1 次保持不变。 最近一期申报(Q2 2025)显示持股 230,128 股、市值约 US$7.2M,环比增持 71,953 股。。 持仓曾出现大幅变动:Q1 2024 减持约 76% (随后一个季度股价下跌 28%)、Q2 2024 增持约 682% (随后一个季度股价下跌 5%)、Q2 2025 增持约 45% (随后一个季度股价下跌 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 72.91K | $3.84M | 新进 |
| Q4 2023 | 61.62K | $3.45M | 减持 |
| Q1 2024 | 14.92K | $931.75K | 减持 |
| Q2 2024 | 116.73K | $5.28M | 增持 |
| Q3 2024 | 139.86K | $6.02M | 增持 |
| Q4 2024 | 139.81K | $6.13M | 持有 |
| Q1 2025 | 158.18K | $6.04M | 增持 |
| Q2 2025 | 230.13K | $7.22M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ENOV 与 13F 数据
ENOV(ENOVIS CORPORATION)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 ENOV,申报仓位最大的包括:Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PARADIGM CAPITAL MANAGEMENT INC/NY (US$28.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ENOV 的基金
- Rubric Capital Management LP 3.90M 股 · $80.73M · Q2 2026
- OAKTREE CAPITAL MANAGEMENT LP 39.21M 股 · $37.79M · Q2 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 1.38M 股 · $28.53M · Q2 2026
更多关于 BERNZOTT CAPITAL ADVISORS
常见问题
How long has BERNZOTT CAPITAL ADVISORS held ENOV?
BERNZOTT CAPITAL ADVISORS has disclosed ENOV holdings in 8 of the last 8 reported quarters, going back to Q3 2023.
What is BERNZOTT CAPITAL ADVISORS's current position in ENOV?
As of Q2 2025, BERNZOTT CAPITAL ADVISORS holds 230.13K shares of ENOV (ENOVIS CORPORATION), valued at $7.22M, representing 3.68% of its reported portfolio and ranking #8.
Has BERNZOTT CAPITAL ADVISORS been buying or selling ENOV?
In the latest 13F filing (Q2 2025), BERNZOTT CAPITAL ADVISORS increased its position in ENOV. The position peaked in Q2 2025 at 230.13K shares.
Which other funds hold ENOV?
Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PARADIGM CAPITAL MANAGEMENT INC/NY, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.